Odyssean »

Omnicell shares owned by Odyssean

Quarter-by-quarter ownership of Omnicell (OMCL) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Omnicell

Tip: Access up to 7 years of quarterly data

All positions including Omnicell held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Omnicell by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.2M 54k 41.52

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Omnicell

BlackRock
Vanguard Portfolio Management
Wellington Management Company
Dimensional Fund Advisors
Millennium Management
Vanguard Capital Management
State Street Corporation
Nomura Asset Management International
Geode Capital Management
Two Sigma Investments
Arrowstreet Capital, Limited Partnership
Charles Schwab Investment Management
Morgan Stanley
Renaissance Technologies
Bank of America Corporation

View all funds holding Omnicell